Dosar de subiect
Experimental Pill Shows Promise for Pancreatic Cancer
Primul articol: 15 apr. 2026, 15:53
|
Ultima actualizare: 15 apr. 2026, 15:53
|
1 sursa
|
1 articol
Mai multe surse. Mai putina manipulare.
Analiza editoriala
Bazat pe 1 sursa, 1 articol
An experimental pill designed to treat pancreatic cancer has shown positive results in a late-stage clinical trial. The study indicates that the pill can improve survival rates for patients with advanced stages of the disease. This development offers hope for a more effective treatment option for pancreatic cancer.Articole despre acest subiect
Foto: France 24
Experimental pancreatic cancer pill helps improve survival in late-stage study
Revolution Medicines' experimental oral drug helped patients with pancreatic cancer live longer and showed an improvement in survival without worsening of the disease in a keenly anticipated late-stage trial. Patients who received the once-daily pill, daraxonrasib, showed a median overall survival of 13.2 months compared with 6.7 months for those who were given intravenous cytotoxic chemotherapy, the standard of care, the company said on Monday.
Citeste pe France 24 →